RodrÃguez-Lopez, A.; MartÃnez-Sendino, M.; Prieto-Pérez, R.; Soria-Chacartegui, P.; González-Iglesias, E.; Aparicio-DomÃnguez, M.; Berenguer-Ruiz, S.; Daudén, E.; Abad-Santos, F.
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers. Biomedicines 2025, 13, 5.
https://doi.org/10.3390/biomedicines13010005
AMA Style
RodrÃguez-Lopez A, MartÃnez-Sendino M, Prieto-Pérez R, Soria-Chacartegui P, González-Iglesias E, Aparicio-DomÃnguez M, Berenguer-Ruiz S, Daudén E, Abad-Santos F.
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers. Biomedicines. 2025; 13(1):5.
https://doi.org/10.3390/biomedicines13010005
Chicago/Turabian Style
RodrÃguez-Lopez, Andrea, MarÃa MartÃnez-Sendino, RocÃo Prieto-Pérez, Paula Soria-Chacartegui, Eva González-Iglesias, Mario Aparicio-DomÃnguez, Sonsoles Berenguer-Ruiz, Esteban Daudén, and Francisco Abad-Santos.
2025. "Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers" Biomedicines 13, no. 1: 5.
https://doi.org/10.3390/biomedicines13010005
APA Style
RodrÃguez-Lopez, A., MartÃnez-Sendino, M., Prieto-Pérez, R., Soria-Chacartegui, P., González-Iglesias, E., Aparicio-DomÃnguez, M., Berenguer-Ruiz, S., Daudén, E., & Abad-Santos, F.
(2025). Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers. Biomedicines, 13(1), 5.
https://doi.org/10.3390/biomedicines13010005
